ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

5.83

+0.16 (2.82%)

At close: Jul 29, 2026, 4:00 PM EDT

5.82

-0.01 (-0.17%)

Pre-market: Jul 30, 2026, 8:12 AM EDT

ARS Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	98.99	84.28	89.15	0.03	1.32	5.51
Revenue Growth	1.92%	-5.46%	297063.33%	-97.72%	-76.10%	-
Gross Profit	73.37	63.86	88.17	0.03	1.32	5.51
Operating Income	-202.42	-179.45	-3.08	-67.52	-35.52	-19.45
Net Income	-197.98	-171.3	8	-54.37	-34.68	-20.24
Earnings Per Share	-2.01	-1.74	0.08	-0.57	-0.87	-0.70
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	81.88	72.19	7.26	0.03	1.32	5.51
Rest of World	-	12.09	81.89	-	-	-
Total	98.99	84.28	89.15	0.03	1.32	5.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	200.97	244.99	314.02	228.36	274.38	60.06
Total Debt	97.11	96.96	0.04	0.27	0.48	9.03
Net Cash (Debt)	103.86	148.02	313.98	228.09	273.9	51.03
Net Cash Growth	-62.32%	-52.86%	37.66%	-16.73%	436.74%	-86.66%
Net Cash Per Share	1.05	1.50	3.07	2.40	6.86	1.77

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-175.07	-170.87	13.55	-59.27	-40.08	-17.56
Capital Expenditures	-0.2	-0.34	-0.56	-0.18	-0.2	-0.06
Free Cash Flow	-175.27	-171.21	12.99	-59.44	-40.28	-17.62
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	74.12%	75.77%	98.90%	100.00%	100.00%	100.00%
Operating Margin	-204.49%	-212.92%	-3.46%	-225067.00%	-2698.78%	-353.32%
Pretax Margin	-204.49%	-203.35%	9.29%	-181216.67%	-2709.42%	-353.32%
Profit Margin	-200.00%	-203.25%	8.97%	-181217.00%	-2635.41%	-367.65%
FCF Margin	-177.06%	-203.14%	14.57%	-198137.00%	-3060.56%	-319.94%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	131.88	-	-	-
P/FCF Ratio	-	-	79.59	-	-	-
PS Ratio	5.85	13.73	11.59	17611.80	608.92	36.73